Member Paolo of The Contrarian, who is a managing director of a capital markets firm based out of London, has a unique passion and affinity for researching biotechnology equities. Throughout the past ...

1. Nature Biotechnology published the letter, which 165 biotech executives signed, that details the industry’s “deep concern and opposition to the executive order.” 2. The letter says of the nearly 69 ...

Paolos_Biotech_Notes_-_AKAO.pdfThis is the second in the new series for members, tentatively titled Paolo's Biotech Notes. To view the first article, and an introduction on the series, please click ...